ArriVent BioPharma AVBP
NASDAQ AVBP
$13.51 +0.02 (+0.11%)
At close: Nov 11, 2026 · 4:00 PM EST

ArriVent BioPharma (AVBP) EBT Margin (2026)

Updated

Analysis

ArriVent BioPharma (AVBP) EBT Margin (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.13%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 27.75%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 26.27%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 45.21%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.90%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 20.41%
10 ArriVent BioPharma 690.85 Mn -714.69 Mn - -806.26%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -806.26%
API Access

ArriVent BioPharma EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=AVBP&period=max&api_key=YOUR_API_KEY